Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCI. (Q39343733)

11 September 2017

Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCI. (English)

1 reference

11 September 2017

1 reference

10

J O Rinne

1 reference

11 September 2017

N M Kemppainen

1

1 reference

11 September 2017

N M Scheinin

2

1 reference

11 September 2017

J Koivunen

3

1 reference

11 September 2017

J Johansson

4

1 reference

11 September 2017

J T Toivonen

5

1 reference

11 September 2017

K Någren

6

1 reference

11 September 2017

J Rokka

7

1 reference

11 September 2017

M Karrasch

8

1 reference

11 September 2017

R Parkkola

9

1 reference

11 September 2017

27 September 2013

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

11 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 September 2017

41

1 reference

11 September 2017

2

1 reference

11 September 2017

283-289

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-013-2562-0

11 September 2017

0 references

cites work

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

PET imaging of amyloid deposition in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2562-0

10.1007/S00259-013-2562-0

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference